Oppenheimer & Co. Inc.

Oppenheimer’s European Consumer Investment Banking Team is pleased to have acted as Financial Adviser to Lantmännen Unibake on its acquisition of Boboli Benelux B.V. https://lnkd.in/efYEf5Gs

We are pleased to have acted as Joint Sales Agent on Capricor Therapeutics, Inc.'s $150.0 Million ATM Offering https://lnkd.in/eckgxdTQ

We are delighted to announce that Oppenheimer has been named a finalist at the Captive Review European Awards 2025 in the category of Investment Firm. This recognition highlights our commitment to excellence in the captive space and reflects the expertise and dedication of our team — including the leadership and contributions of Jack Meskunas, MBA, ACI — in delivering exceptional results for our clients and partners. #ThePowerofOppenheimerThinking

Yesterday, during UN General Assembly week here in New York, Oppenheimer President & CEO Robert Lowenthal joined a roundtable hosted by President Shavkat Mirziyoyev of Uzbekistan, alongside global business leaders and U.S. officials. The discussions focused on expanding cooperation across critical sectors including supply chains, technology, energy, infrastructure, and smart agriculture. We are proud to contribute to dialogues that strengthen global partnerships and connect capital with opportunity. #ThePowerofOppenheimerThinking #UNGA 

We were proud to once again sponsor The Nicholas Center’s Annual Day of Golf at North Hempstead Country Club. With more than 130 golfers — including over 50 of our colleagues, past and present — the outing raised $170,000+ to support programs that empower Autistic individuals through vocational training, supported employment, and community inclusion. Each year, this event also honors the memory of our friend and partner Steve Scrobe, whose dedication to the Autism community continues to inspire us all. It is a privilege to help carry forward his legacy through this special day. Congratulations to The Nicholas Center, Spectrum Designs Foundation, the event hosts, and all the generous sponsors who made this impactful outing possible. #ThePowerofOppenheimerThinking

Gargantuan challenges and the hurdles they have raised to progress have been met head on and repeatedly by upside in the markets giving credence to the old adage “the darkest hour comes before the dawn.” https://lnkd.in/exBmDRpV

Since July, Oppenheimer has been the second most active lead-left bookrunner in the convertible market – demonstrating the depth of our execution capabilities across healthcare and other sector. Our team successfully acted as bookrunner on four transactions, sole-managing three of them: ✔️ BlackSky – Convertible offering to refinance debt and fund growth initiatives; upsized and priced at the best end of the coupon and conversion premium range. ✔️ Evolent – Convertible offering to refinance debt and repurchase common stock; upsized and priced better than the best end of the coupon and conversion premium range. ✔️ WisdomTree – Convertible offering to fund an acquisition and repurchase common stock; upsized and priced at the best end of the coupon and conversion premium range. ✔️ Ligand Pharmaceuticals – Convertible offering to fund investments and repurchase common stock; priced at the best end of the coupon and conversion premium range. ✔️ Enovix Corporation – Convertible offering to fund growth initiatives; priced at the mid-point of the coupon range. ✔️ Gladstone Capital Corporation – Convertible offering to refinance debt and fund investments; upsized and priced at the mid-point of the marketing range. This momentum underscores our team’s ability to deliver tailored capital solutions, support strategic initiatives, and help innovative companies — in healthcare and beyond — achieve their growth ambitions. #ThePowerofOppenheimerThinking 

We are pleased to announce the appointment of six senior London-based professionals to our High Yield and Distressed Credit business. The new team members include: Mike Paget, Managing Director & Head of High Yield and Distressed Sales and Trading Michael Levy, Managing Director & Head of High Yield and Distressed Trading Marc Magliana, Managing Director & Head of High Yield and Distressed Sales Matthew Smith, Managing Director, Loans and Distressed Trading Nicolas Bourguignon, Managing Director, Head of High Yield and Distressed Research Andrew De Almeida, Executive Director, Business Manager, High Yield and Distressed Fixed Income These appointments reinforce our commitment to expanding in Europe and enhancing our global platform. By working in close collaboration with our teams in the U.S. and Asia, the London team will help deliver seamless cross-border coverage, insights, and execution for clients worldwide. Learn more: https://lnkd.in/ek5S_-C5 #ThePowerofOppenheimerThinking

Today, Oppenheimer had the honor of hosting Laziz Kudratov, Minister of Investments of the Republic of Uzbekistan, along with an official delegation visiting the United States. They were welcomed by Robert Lowenthal, President & CEO of Oppenheimer, and engaged in productive discussions on ongoing initiatives, future projects, and opportunities for collaboration between Oppenheimer and the Republic of Uzbekistan. We are excited about the possibilities ahead and the continued strengthening of this important relationship. #ThePowerofOppenheimerThinking

Sticky inflation and dramatic drops in stateside jobs numbers have raised the volume of angst around the question, “when is the Fed going to cut rates? https://lnkd.in/e2WM5DQ3